These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

553 related items for PubMed ID: 31047672

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Leishmania infantum HSP70-II null mutant as candidate vaccine against leishmaniasis: a preliminary evaluation.
    Carrión J, Folgueira C, Soto M, Fresno M, Requena JM.
    Parasit Vectors; 2011 Jul 27; 4():150. PubMed ID: 21794145
    [Abstract] [Full Text] [Related]

  • 6. Coadministration of the Three Antigenic Leishmania infantum Poly (A) Binding Proteins as a DNA Vaccine Induces Protection against Leishmania major Infection in BALB/c Mice.
    Soto M, Corvo L, Garde E, Ramírez L, Iniesta V, Bonay P, Gómez-Nieto C, González VM, Martín ME, Alonso C, Coelho EA, Barral A, Barral-Netto M, Iborra S.
    PLoS Negl Trop Dis; 2015 May 27; 9(5):e0003751. PubMed ID: 25955652
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Live Attenuated Leishmania donovani Centrin Gene-Deleted Parasites Induce IL-23-Dependent IL-17-Protective Immune Response against Visceral Leishmaniasis in a Murine Model.
    Banerjee A, Bhattacharya P, Dagur PK, Karmakar S, Ismail N, Joshi AB, Akue AD, KuKuruga M, McCoy JP, Dey R, Nakhasi HL.
    J Immunol; 2018 Jan 01; 200(1):163-176. PubMed ID: 29187586
    [Abstract] [Full Text] [Related]

  • 10. Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis.
    Mizbani A, Taheri T, Zahedifard F, Taslimi Y, Azizi H, Azadmanesh K, Papadopoulou B, Rafati S.
    Vaccine; 2009 Dec 10; 28(1):53-62. PubMed ID: 19818721
    [Abstract] [Full Text] [Related]

  • 11. Characterization of cross-protection by genetically modified live-attenuated Leishmania donovani parasites against Leishmania mexicana.
    Dey R, Natarajan G, Bhattacharya P, Cummings H, Dagur PK, Terrazas C, Selvapandiyan A, McCoy JP, Duncan R, Satoskar AR, Nakhasi HL.
    J Immunol; 2014 Oct 01; 193(7):3513-27. PubMed ID: 25156362
    [Abstract] [Full Text] [Related]

  • 12. Reduced pathogenicity of fructose-1,6-bisphosphatase deficient Leishmania donovani and its use as an attenuated strain to induce protective immunogenicity.
    Saini S, Ghosh AK, Das S, Singh R, Abhishek K, Verma S, Kumar A, Mandal A, Purkait B, Sinha KK, Das P.
    Vaccine; 2018 Feb 21; 36(9):1190-1202. PubMed ID: 29395522
    [Abstract] [Full Text] [Related]

  • 13. Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis.
    Bhattacharya P, Dey R, Dagur PK, Joshi AB, Ismail N, Gannavaram S, Debrabant A, Akue AD, KuKuruga MA, Selvapandiyan A, McCoy JP, Nakhasi HL.
    PLoS Negl Trop Dis; 2016 Aug 21; 10(8):e0004963. PubMed ID: 27580076
    [Abstract] [Full Text] [Related]

  • 14. Intracellular replication-deficient Leishmania donovani induces long lasting protective immunity against visceral leishmaniasis.
    Selvapandiyan A, Dey R, Nylen S, Duncan R, Sacks D, Nakhasi HL.
    J Immunol; 2009 Aug 01; 183(3):1813-20. PubMed ID: 19592661
    [Abstract] [Full Text] [Related]

  • 15. DDX3 DEAD-box RNA helicase (Hel67) gene disruption impairs infectivity of Leishmania donovani and induces protective immunity against visceral leishmaniasis.
    Pandey SC, Pande V, Samant M.
    Sci Rep; 2020 Oct 26; 10(1):18218. PubMed ID: 33106577
    [Abstract] [Full Text] [Related]

  • 16. Leishmania donovani serine protease encapsulated in liposome elicits protective immunity in experimental visceral leishmaniasis.
    Das P, Paik D, Naskar K, Chakraborti T.
    Microbes Infect; 2018 Jan 26; 20(1):37-47. PubMed ID: 28970116
    [Abstract] [Full Text] [Related]

  • 17. A Non-pathogenic Recombinant Leishmania Expressing Lipophosphoglycan 3 Against Experimental Infection with Leishmania infantum.
    Pirdel L, Farajnia S.
    Scand J Immunol; 2017 Jul 26; 86(1):15-22. PubMed ID: 28426153
    [Abstract] [Full Text] [Related]

  • 18. Generation of growth arrested Leishmania amastigotes: a tool to develop live attenuated vaccine candidates against visceral leishmaniasis.
    Selvapandiyan A, Dey R, Gannavaram S, Solanki S, Salotra P, Nakhasi HL.
    Vaccine; 2014 Jun 30; 32(31):3895-901. PubMed ID: 24837513
    [Abstract] [Full Text] [Related]

  • 19. Recombinant small glutamine-rich tetratricopeptide repeat-containing protein of Leishmania infantum: Potential vaccine and diagnostic application against visceral leishmaniasis.
    Dias DS, Ribeiro PAF, Martins VT, Lage DP, Portela ÁSB, Costa LE, Salles BCS, Lima MP, Ramos FF, Santos TTO, Caligiorne RB, Chávez-Fumagalli MA, Silveira JAG, Magalhães-Soares DF, Gonçalves DU, Oliveira JS, Roatt BM, Duarte MC, Menezes-Souza D, Silva ES, Galdino AS, Machado-de-Ávila RA, Teixeira AL, Coelho EAF.
    Mol Immunol; 2017 Nov 30; 91():272-281. PubMed ID: 28988041
    [Abstract] [Full Text] [Related]

  • 20. Leishmania genome analysis and high-throughput immunological screening identifies tuzin as a novel vaccine candidate against visceral leishmaniasis.
    Lakshmi BS, Wang R, Madhubala R.
    Vaccine; 2014 Jun 24; 32(30):3816-22. PubMed ID: 24814525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.